{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T12:20:17Z","timestamp":1681734017411},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1994,3,1]],"date-time":"1994-03-01T00:00:00Z","timestamp":762480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1994,3,1]],"date-time":"1994-03-01T00:00:00Z","timestamp":762480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[1994,3]]},"DOI":"10.1007\/bf00873240","type":"journal-article","created":{"date-parts":[[2004,12,27]],"date-time":"2004-12-27T23:59:32Z","timestamp":1104191972000},"page":"67-70","source":"Crossref","is-referenced-by-count":3,"title":["Phase II trial of menogaril in metastatic adenocarcinoma of the prostate"],"prefix":"10.1007","volume":"12","author":[{"given":"Sarah A.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brent A.","family":"Blumenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald L.","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. David","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernie","family":"Pistone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian B.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00873240_CR1","first-page":"1971","volume":"63","author":"GL Neil","year":"1979","unstructured":"Neil GL, Kuentzel SL, McGovern JP: Treatment of mouse tumors with 7-con-o-methylenogariel and other analogs of the anthracycline antibiotics, nogalamycin. Cancer Treat Rep 63:1971\u20131978, 1979","journal-title":"Cancer Treat Rep"},{"key":"BF00873240_CR2","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1200\/JCO.1986.4.5.767","volume":"4","author":"P Dodion","year":"1986","unstructured":"Dodion P, Sessa C, Joss R, Crespeigne N, Williams Y, Kitt M, Adams WJ, Finet C, Brewer JE, Adams WJ, Earhart RH, Rozencweig M, Kenis Y, Cavalli F: Phase I study of intravenous menogaril administered intermittently. J Clin Oncol 4:767\u2013774, 1986","journal-title":"J Clin Oncol"},{"key":"BF00873240_CR3","first-page":"2562","volume":"46","author":"FA Dorr","year":"1986","unstructured":"Dorr FA, Van Hoff DD, Kuhn JG, Schwartz R, Kisnor DL: Phase I clinical investigation of 7-con-o-methylnogaril, a new anthracycline antibiotic. Cancer Res 46: 2562\u20132565, 1986","journal-title":"Cancer Res"},{"key":"BF00873240_CR4","first-page":"721","volume":"70","author":"LM Sigman","year":"1986","unstructured":"Sigman LM, Van Echo DA, Egorin MJ, Whitacre MY, Aisner J: Phase I trial of menogaril administered as an intermittent daily infusion for 5 days. Cancer Treat Rep 70:721\u2013725, 1986","journal-title":"Cancer Treat Rep"},{"key":"BF00873240_CR5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2307\/2530297","volume":"38","author":"TR Fleming","year":"1982","unstructured":"Fleming TR: One-sample multiple testing procedures for phase II clinical trials. Biometrics 38:143\u2013151, 1982","journal-title":"Biometrics"},{"key":"BF00873240_CR6","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/1097-0142(197911)44:5<1553::AID-CNCR2820440502>3.0.CO;2-W","volume":"44","author":"A Yagoda","year":"1976","unstructured":"Yagoda A, Watson RC, Natale RB et al.: A critical analysis of response criteria in patients with prostatic cancer treated with cis-diamine dichloride platinum II. Cancer 44:1553\u20131562, 1976","journal-title":"Cancer"},{"key":"BF00873240_CR7","first-page":"115","volume":"60","author":"RT Eagan","year":"1976","unstructured":"Eagan RT, Hahn RG, Myers RP: Adriamycin (NSC-123127) versus 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC 26271) in the treatment of metastatic prostate cancer. Cancer Treat Rep 60:115\u2013117, 1976","journal-title":"Cancer Treat Rep"},{"key":"BF00873240_CR8","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/0090-4295(76)90085-6","volume":"7","author":"JD Schmidt","year":"1976","unstructured":"Schmidt JD, Johnson DE, Scott WW, Gibbons RP, Prout GR Jr, Murphy GP: The National Prostatic Cancer Project: Chemotherapy of advanced prostatic cancer, evaluation of response parameters. Urology 7:602\u2013610, 1976","journal-title":"Urology"},{"key":"BF00873240_CR9","first-page":"325","volume":"61","author":"WD DeWys","year":"1977","unstructured":"DeWys WD, Bauer M, Colsky J, Cooper RA, Creech R, Carbone PP: Comparative trial of Adriamycin and 5-fluorouracil in advanced prostatic cancer: Progress report. Cancer Treat Rep 61:325\u2013328, 1977","journal-title":"Cancer Treat Rep"},{"key":"BF00873240_CR10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/bjc.1975.135","volume":"32","author":"NH Slack","year":"1975","unstructured":"Slack NH, Bross IDJ: The influence of site of metastasis on tumor growth and response to chemotherapy. Br J Cancer 32:78\u201386, 1975","journal-title":"Br J Cancer"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00873240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00873240\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00873240","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00873240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T17:39:33Z","timestamp":1678556373000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00873240"}},"subtitle":["A Southwest Oncology Group study"],"short-title":[],"issued":{"date-parts":[[1994,3]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1994,3]]}},"alternative-id":["BF00873240"],"URL":"https:\/\/doi.org\/10.1007\/bf00873240","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,3]]}}}